Overview
Suthee Rapisuwon is a Hematologist and an Oncologist in Washington, Washington, D.c.. Dr. Rapisuwon is rated as an Experienced provider by MediFind in the treatment of Uveal Melanoma. His top areas of expertise are WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), and Melanoma.
His clinical research consists of co-authoring 22 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles and participated in 1 clinical trial in the study of Uveal Melanoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
110 Irving St Nw, Washington, DC 20010
Additional Areas of Focus
Dr. Rapisuwon has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
5 Clinical Trials
The Johns Hopkins Hospital
James T. Handa, M.D., is Chief of the Retina Division and the Robert Bond Welch, M.D., Professor of Ophthalmology at the Wilmer Eye Institute. He specializes in medical and surgical management of complex vitreoretinal diseases such as age-related macular degeneration, diabetic retinopathy, retinal detachment, retinopathy of prematurity and other pediatric retinal diseases. He also has expertise in intraocular oncology and manages patients with choroidal melanomas and metastatic tumors of the eye. Not only is he a highly skilled surgeon and clinician, but he also devotes significant effort to research related to the early causes of age-related macular degeneration using molecular pathological approaches to understand how the eye transforms from normal aging to early disease. He has been funded by the National Eye Institute for the last 19 years, and he currently holds two R01 awards for his work in AMD. He has also been funded by the Thome Foundation, Research to Prevent Blindness, Fight for Sight and the American Health Assistance Foundation. His other research focuses on surgical innovation using an integrated robotic surgical system. Dr. Handa is currently the Wilmer Eye Institute’s implanting surgeon for the Argus II retinal chip implant, which was recently approved by the FDA after Dr. Handa participated in the clinical trial leading to its approval. Dr. Handa is rated as a Distinguished provider by MediFind in the treatment of Uveal Melanoma. His top areas of expertise are Melanoma of the Eye, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Metastatic Uveal Melanoma, and Vitrectomy.
Mgmc LLC
Geoffrey Gibney is a Hematologist and an Oncologist in Washington, Washington, D.c.. Dr. Gibney is rated as a Distinguished provider by MediFind in the treatment of Uveal Melanoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Olfactory Neuroblastoma, and Sinus Cancer.
Marc Ernstoff is an Oncologist in Frederick, Maryland. Dr. Ernstoff is rated as a Distinguished provider by MediFind in the treatment of Uveal Melanoma. His top areas of expertise are Melanoma, Renal Cell Carcinoma (RCC), Neuroendocrine Tumor, and Urothelial Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chromophobe Renal Cell CarcinomaDr. Rapisuwon isDistinguished. Learn about Chromophobe Renal Cell Carcinoma.
- MelanomaDr. Rapisuwon isDistinguished. Learn about Melanoma.
- Muscle Invasive Bladder CancerDr. Rapisuwon isDistinguished. Learn about Muscle Invasive Bladder Cancer.
- Renal Cell Carcinoma (RCC)Dr. Rapisuwon isDistinguished. Learn about Renal Cell Carcinoma (RCC).
- WT1-Related Wilms Tumor SyndromesDr. Rapisuwon isDistinguished. Learn about WT1-Related Wilms Tumor Syndromes.
- Advanced
- Adult Soft Tissue SarcomaDr. Rapisuwon isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Bladder CancerDr. Rapisuwon isAdvanced. Learn about Bladder Cancer.
- Breast CancerDr. Rapisuwon isAdvanced. Learn about Breast Cancer.
- Clear Cell SarcomaDr. Rapisuwon isAdvanced. Learn about Clear Cell Sarcoma.
- Familial Prostate CancerDr. Rapisuwon isAdvanced. Learn about Familial Prostate Cancer.
- Familial Wilms Tumor 2Dr. Rapisuwon isAdvanced. Learn about Familial Wilms Tumor 2.
- Experienced
- Alveolar Soft Part SarcomaDr. Rapisuwon isExperienced. Learn about Alveolar Soft Part Sarcoma.
- Bone TumorDr. Rapisuwon isExperienced. Learn about Bone Tumor.
- Brain TumorDr. Rapisuwon isExperienced. Learn about Brain Tumor.
- DICER1 SyndromeDr. Rapisuwon isExperienced. Learn about DICER1 Syndrome.
- Eccrine PorocarcinomaDr. Rapisuwon isExperienced. Learn about Eccrine Porocarcinoma.
- Epithelioid SarcomaDr. Rapisuwon isExperienced. Learn about Epithelioid Sarcoma.